Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Breast Cancer Res Treat. 2019 Aug 27;178(3):587–595. doi: 10.1007/s10549-019-05416-4

Table 1.

Demographic and clinical characteristics of women after treatment of breast cancer (n = 49)

Mean age (SD, range) 61.6 (10.1, 35.5–86.0)
Mean BMI (SD, range) 27.8 (5.2, 19.1–44.7)
Race [N (%)]
 White 31 (63.3%)
 Black or African American 9 (18.4%)
 Asian 5 (10.2%)
 Other 1 (2%)
 Unknown 3 (6.1%)
Chemotherapy [N (%)]
 Taxane-based only 44 (89.8%)
 Taxane and platinum combined 5 (10.2%)
Time (year) from Chemotherapy Completion (Median, Range) 3 (0.26–18)
Mean subjective measures (SD, Range)
 NRS pain 4.2 (2.6, 0–8)
 NRS numbness 5.7 (2.3, 0–10)
 NRS tingling 4.4 (2.7, 0–10)
 NPS 41.0 (22.4, 0–84)
 FACT/GOG-Ntx 25.8 (6.8, 8–40)